AR and posterior cortical atrophy: Endocrine therapy in PCa is aimed at lowering serum androgen levels and inhibiting androgen receptor; when this approach fails, PCa advances to a hormone-resistant state (Heinlein and Chang, 2004; Shafi et al., 2013).